Moreover, our findings revealed a decrease of VCAM1 expression in RA-ILD+ patients with respect to the comparative groups, suggesting the involvement of post-transcriptional regulatory mechanisms (Greenbaum et al., 2003; Stevens and Brown, 2013; Li et al., 2020). This evidence concerns the gene VCAM1 and interstitial lung disease.